Brief: Zynerba Pharmaceuticals Inc Intends To Seek Approval Of Reverse Stock Split At Annual Meeting
15/05/2023 12:41
May 15 (Reuters) - Zynerba Pharmaceuticals Inc ZYNE.O :
* ZYNERBA PHARMACEUTICALS INC- INTENDS TO SEEK APPROVAL OF
REVERSE STOCK SPLIT AT ANNUAL MEETING IN JUNE, WHICH IT WOULD
EFFECT ANY TIME PRIOR TO NOV 1
Source text for Eikon: ID:
Further company coverage: ZYNE.O
Recent news on Zynerba Pharmaceuticals
See all newsBrief: Harmony Biosciences Completes Acquisition Of Zynerba Pharmaceuticals
Brief: Harmony Biosciences Announces Extension Of Tender Offer To Acquire Zynerba Pharmaceuticals, Inc.
Brief: Zynerba Pharmaceuticals Presents Positive Data From Phase 2 Inspire Trial
U.S. RESEARCH ROUNDUP-Easterly Government Properties, Visa, Zynerba Pharmaceuticals
Zynerba Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary